Construction method and application of endothelial cell 6030442E23Rik gene specific knockout mouse model

By constructing a mouse model of endothelial cell 6030442E23Rik gene-specific knockout, the technical difficulties in vascular aging research were solved, efficient vascular function improvement and potential treatment strategies were achieved, and it has high clinical value.

CN119014373AActive Publication Date: 2024-11-26THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIV

Patent Information

Application Number
CN202411453850.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-17
Publication Date
2024-11-26
Estimated Expiration
2044-10-17

AI Technical Summary

Technical Problem

The prior art is difficult to effectively study and delay specific molecular mechanisms of vascular aging, resulting in difficulty in reducing the incidence and mortality of vascular dysfunction and cardiovascular diseases.

Method used

By constructing a mouse model of 6030442E23Rik gene-specific knockout of endothelial cells, using CRISPR gene editing technology and conditional gene knockout method, combined with Tek-CreERT2 mouse hybridization, specific knockout of 6030442E23Rik gene was achieved, and a high repetition was established by establishing a high repetition Research model with good character and controllability.

Benefits of technology

This model is stable and easy to feed, and can serve as an important research model for vascular endothelial aging. It provides a potential therapeutic strategy to delay vascular aging and improve vascular function, and has high clinical value.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119014373A_ABST
    Figure CN119014373A_ABST
Patent Text Reader

Abstract

The invention discloses a construction method and application of an endothelial cell 6030442E23Rik gene specific knockout mouse model, and belongs to the technical field of genetic engineering.A 6030442E23Rik conditional gene knockout mouse and a Tek-CreERT2 mouse are utilized (Cre is inserted into a mouse Tek gene termination codon by utilizing a CRISPR gene editing technology, the mouse is a tool mouse for conditional knockout of endothelial cells, and the mouse is a Tek-CreERT2 mouse. At present, a mouse of the strain has been hybridized in the market, and a 6030442E23Rik- / -Tek-CreERT2 mouse is obtained. And dissolving the Tamoxifen in the corn oil, so that the final concentration of the Tamoxifen is 20 mg / ml. The method comprises the following steps: taking a mouse as a template, taking the mouse as a template, injecting the template into the template for 5 times in the abdominal cavity according to the Tamoxifen dosage of 120mg / kg of the body weight of the mouse, and injecting once every other day, so as to obtain the mouse model with the endothelial cell 6030442E23Rik specifically knocked out 7 days after the last time of injection is finished. The invention discloses an endothelial cell 6030442E23Rik specific knockout mouse model, which is an important mouse model for researching vascular endothelial senescence.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of genetic engineering, and in particular relates to a method for constructing an endothelial cell 6030442E23Rik gene-specific knockout mouse model and an application thereof. Background Art

[0002] The increasingly aging society in the world is one of the major public health challenges around the world. Aging is the most important cardiovascular risk factor. Vascular aging is a structural abnormality and functional disorder in the aging process of individuals, characterized by increased vascular cell aging, vascular dysfunction, and vascular remodeling. Vascular endothelial cells are a highly dynamic monolayer of cells located between the vascular wall and the blood, and are considered to be the most important component for maintaining vascular homeostasis. An increasing number of studies have shown that endothelial aging is a trigger for vascular aging and even individual aging. Therefore, further understanding of the specific molecular mechanisms of aging-induced endothelial dysfunction may provide new therapeutic options for delaying vascular aging and reducing the morbidity and mortality of age-related cardiovascular diseases.

[0003] Long noncoding RNA (lncRNA) is a type of noncoding RNA with a length greater than 200 nt, and is an important component of the noncoding genome. A large number of studies have shown that lncRNAs are involved in a variety of biological processes, including cell aging, DNA methylation, histone modification, RNA post-transcriptional regulation, and protein translation regulation, and affect the regulation of various physiological and pathological processes. They are important molecules for regulating genes in cells and even individuals.

[0004] In the early stage, we used aged and young aortic tissues, combined with lncRNA array technology, to screen out the age-related lncRNA - 6030442E23Rik, and named it "Aging Associated Transcript" (AAT). In addition, we have verified in mouse aortic tissue and mouse aortic endothelial cells that the expression of 6030442E23Rik will continue to increase with age, and after 6030442E23Rik endothelial knockout, the vascular endothelial function of mice is improved, energy metabolism is activated, and activity is enhanced.

[0005] In general, humans also have an AAT sequence that is homologous to that of mice, and targeting this sequence is expected to become a potential therapeutic strategy to delay vascular aging and improve vascular function. Summary of the invention

[0006] In response to the above problems, the present invention adopts the method of homologous recombination of fertilized eggs, hybridizes 6030442E23Rik conditional gene knockout mice with Tek-CreERT2 mice, and creates an endothelial cell 6030442E23Rik gene-specific knockout mouse model.

[0007] One object of the present invention is to provide a method for constructing an endothelial cell 6030442E23Rik gene-specific knockout mouse model, the construction method comprising:

[0008] 6030442E23Rik conditional knockout mice were hybridized with Tek-CreERT2 mice to obtain 6030442E23Rik - / - Tek-CreERT2 mice; Tamoxifen was dissolved in corn oil to a final concentration of 20 mg / ml, and injected intraperitoneally 5 times at a dose of 120 mg / kg mouse body weight, once every other day. A mouse model with endothelial cell 6030442E23Rik specific knockout was obtained 7 days after the last injection.

[0009] Furthermore, the construction process of Tek-CreERT2 mice includes:

[0010] CRISPR gene editing technology was used to insert Cre into the stop codon of the mouse Tek gene to obtain Tek-CreERT2 mice.

[0011] Furthermore, the construction process of 6030442E23Rik conditional knockout mice includes:

[0012] Cas9 mRNA and gRNA were obtained by in vitro transcription; homologous recombination vectors were constructed by In-Fusion cloning; Cas9 mRNA, gRNA and homologous recombination vectors were microinjected into fertilized eggs of C57BL / 6J mice to obtain F0 mice, and the F0 mice that were positive were identified by PCR amplification and sequencing. The F0 mice that were positive were mated with C57BL / 6J mice to obtain positive F1 mice.

[0013] Furthermore, the primer sequence of gRNA includes gRNA1 and gRNA2, and the nucleotide sequences of gRNA1 and gRNA2 are as follows:

[0014] gRNA1: 5'-GCCAATAAGGTTTTATCAGCTGG-3';

[0015] gRNA2: 5'-GCTGGAGACCTTATTCTATTGGG-3'.

[0016] Furthermore, the homologous recombination vector comprises a 2.9 kb 5' homology arm, a 2.2 kb flox region and a 2.6 kb 3' homology arm.

[0017] Furthermore, the F0 generation mouse identification scheme is as follows:

[0018] The 5' arm homologous recombination positive genome should amplify a 5.4kb fragment, and the negative genome should amplify a 8.3kb fragment; the 3' arm homologous recombination positive genome should amplify a 5.7kb fragment, and the negative genome should amplify a 9.4kb fragment.

[0019] Furthermore, the PCR primer sequences for the 5' homology arm are as follows:

[0020] Forward-GGCATGGTAAAGGATTCACATCAAA;

[0021] Reverse-TACACTCTTGATGCTTGGGTTTTC.

[0022] Furthermore, the PCR primer sequences for the 3' homology arms are as follows:

[0023] Forward-TCCTGTGTTGACATAGTTCTTTGGA;

[0024] Reverse-TGTCATGTTTACCTCTCCAGACATT.

[0025] Another object of the present invention is to provide an application of an endothelial cell 6030442E23Rik gene-specific knockout mouse model in the study of vascular endothelial aging.

[0026] Compared with the prior art, the present invention has the following advantages:

[0027] 1. The 6030442E23Rik gene conditional knockout mouse model constructed in this application has high repeatability, good controllability, is easy to raise and breed, and is more stable and more in line with clinical characteristics.

[0028] 2. The expression of 6030442E23Rik gene in mouse aorta (especially aortic endothelial cells) increases with age. This gene may be used as a detection indicator for vascular aging in mice. The mouse model with 6030442E23Rik specific knockout in endothelial cells obtained by hybridizing 6030442E23Rik conditional gene knockout mice with Tek-CreERT2 mice in this application is an important mouse model for studying vascular endothelial aging, and its clinical value is higher. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 Schematic diagram of the strategy for constructing a mouse model with specific knockout of 6030442E23Rik in endothelial cells.

[0030] Figure 2 A strategy diagram for constructing a 6030442E23Rik conditional knockout mouse model, wherein 5'homologyarm: 5'homology arm, 3'homology arm: 3'homology arm, Wildtype allele: wild-type allele, Targetingvector: targeting vector, Targeted allele: target allele, Knockout allele: knockout allele, Crerecombination: recombinase gene recombination, Exon1: exon 1, Exon2: exon 2, Coding region: coding region, Uncoding region: non-coding region;

[0031] Figure 3 is the homologous recombination plasmid map;

[0032] Figure 4 Electrophoresis diagram of homologous recombination vector digestion identification, 1: EcoR I digestion identification result, theoretical band sizes are 7594bp, 5614bp, 466bp; M: 1kb DNA ladder;

[0033] Figure 5 Schematic diagram of the identification strategy for F0 generation mice, where homology arm: homology arm, Wild type allele: wild type allele, Targeted allele: target allele, Exon1: exon 1, Exon2: exon 2, Coding region: coding region, Uncoding region: non-coding region, Primer location: primer location, PCR product: PCR product, PCR sequenced region: PCR sequencing region;

[0034] Figure 6 This is the electrophoresis diagram of PCR identification of homologous recombination-positive F0 generation mice. Numbers: F0 generation mouse number; M is 1kb DNA marker;

[0035] Figure 7 This is the electrophoresis diagram for PCR identification of the 5' homology arm and 3' homology arm of F1 generation mice; A-5' homology arm; B-3' homology arm; Numbers: F1 generation mouse number; M: 1kb DNA ladder;

[0036] Figure 8This is a schematic diagram of sequencing verification of PCR products of F1 generation mice;

[0037] Fig. 9 Schematic diagram of F1 generation positive mice;

[0038] Fig.10 Schematic diagram of the subsequent mouse breeding process, Heterozygous flox mouse: heterozygous flox mouse, Cre mouse: Cre recombinase mouse, Homozygous flox mouse: homozygous flox mouse, Heterozygous flox mouse and Cre positive: heterozygous flox / Cre positive mouse, Homozygous flox mouse andCre positive: homozygous flox / Cre positive mouse;

[0039] Fig.11 This is a schematic diagram of the positions of primers for PCR identification of the 6030442E23Rik gene in floxed mice;

[0040] Fig.12 This is the electrophoresis diagram for the restriction enzyme digestion identification of the genotype of the 6030442E23Rik gene in flox mice;

[0041] Fig.13 6030442E23Rik - / - Schematic diagram of the positions of primers for PCR identification of Cre enzyme in Tek-CreERT2 mice;

[0042] Fig.14 6030442E23Rik - / - Genotypic restriction enzyme digestion electrophoresis of Cre enzyme in Tek-CreERT2 mice;

[0043] Fig.15 It is the alignment result of the 1# sequencing reaction of the 5' homology arm of the F1 generation mouse; Query is the target sequence (E23Rikrecombined genomic DNA sequence), Subject is the sequencing result, and the red underline is the 5arm homology arm sequence;

[0044] Fig.16 It is the alignment result of 5' homology arm 2# sequencing reaction of F1 generation mice; Query is the target sequence (E23Rikrecombined genomic DNA sequence), Subject is the sequencing result, the red box base is the Loxp sequence, and the red underline is the 5arm homology arm sequence;

[0045] Fig.17It is the alignment result of the 1# sequencing reaction of the 3' homology arm of the F1 generation mouse; Query is the target sequence (E23Rikrecombined genomic DNA sequence), Subject is the sequencing result, the red box base is the Loxp sequence, and the red underline is the 3arm homology arm sequence;

[0046] Fig.18 It is the alignment result of 3' homology arm 2# sequencing reaction of F1 generation mice; Query is the target sequence (E23Rikrecombined genomic DNA sequence), Subject is the sequencing result, and the red underline is the 3arm homology arm sequence. DETAILED DESCRIPTION

[0047] The present invention is further described below with reference to specific examples.

[0048] The present application provides a method for constructing an endothelial cell 6030442E23Rik gene-specific knockout mouse model, such as Figure 1 As shown, it includes three parts:

[0049] 1. Tek-CreERT2 mice

[0050] In order to add inducible properties to the Cre-lox system, we used the ligand-dependent CreER recombinase. It consists of the fusion of the cre recombinase and the hormone binding domain of the estrogen receptor (ER). Without the action of the estrogen analogue Tamoxifen, the CreER recombinase stays in the cytoplasm and cannot function; only when it binds to estrogen can CreER enter the nucleus and drive the recombination of the LoxP site.

[0051] Using CRISPR gene editing technology, Cre is inserted into the termination codon of the mouse Tek gene, creating a tool mouse for conditional knockout of endothelial cells. This strain of mice is currently available on the market.

[0052] 2. 6030442E23Rik conditional knockout mice

[0053] like Figure 2As shown, the 6030442E23Rik gene was floxed by homologous recombination of fertilized eggs using the principle of homologous recombination. The brief process is as follows: Cas9 mRNA and gRNA were obtained by in vitro transcription; a homologous recombination vector (donor vector) was constructed by In-Fusion cloning, which contained a 2.9kb 5' homology arm, a 2.2kb flox region, and a 2.6kb 3' homology arm. Cas9 mRNA, gRNA, and donor vector were microinjected into fertilized eggs of C57BL / 6J mice to obtain F0 generation mice, and positive F0 generation mice were identified by PCR amplification and sequencing.

[0054] The target gene name (Ensembl number) mentioned above: 6030442E23Rik (ENSMUSG00000100664)

[0055] Ensembl website link of target gene:

[0056] http: / / asia.ensembl.org / Mus_musculus / Gene / Summary?db=core;g=ENSMUSG00000100664;r=7:70866797-70874157;t=ENSMUST00000186618

[0057] Transcript targeted by the protocol (Ensembl number): 6030442E23Rik-201

[0058] (ENSMUST00000186618.2)

[0059] Exon targeted by Flox: exon 1

[0060] 2.1. Design of Guide RNA (gRNA):

[0061] The gRNA design was mainly based on http: / / crispr.mit.edu / and

[0062] http: / / www.rgenome.net / cas-designer / for design: Design by selecting the editing type, selecting the species, inputting the sequence of the target gene, etc.

[0063] The gRNAs sequence information is shown in the following table:

[0064] gRNAs Sequence(5'-3') gRNA1 GCCAATAAGGTTTTATCAGCTGG gRNA2 GCTGGAGACCTTATTCTATTGGG

[0065] 2.2. Construction of homologous recombination plasmid

[0066] 2.2.1 Homologous recombination plasmid map

[0067] Method for constructing homologous recombination plasmid:

[0068] 1. According to the restriction site of the target fragment, select the corresponding endonuclease, cut the circular vector plasmid into a linear vector by double restriction method, and recover the restriction product by agarose gel method;

[0069] 2. Amplify the sequence of the target fragment by PCR and recover the amplified product by agarose gel method;

[0070] 3. Connect the linearized vector and the amplified fragment in proportion at 37°C for 1-2h. Transfer the connected recombinant plasmid (10μl) into the cloning competent cells DH5α, gently blow and mix evenly, let it stand on ice for 30min, then put it in a 42°C water bath for 90s, and immediately put it on ice to cool for 2-3min;

[0071] 4. Add 500 μl of LB liquid medium without antibiotics, shake at 37°C for 1 hour, and rotate at 250 rpm;

[0072] 5. Centrifuge the bacterial solution from the previous step at 5000rpm for 5 minutes and discard 300μl of supernatant. Resuspend the bacterial cells with the remaining culture medium. It is best to apply different gradients to prevent the monoclonal bacteria from being too dense or too sparse. Use a sterile coating stick to spread evenly on the plate containing plasmid resistance, and place it in a 37℃ incubator for 10 to 12 hours;

[0073] 6. After overnight, use a 1μl pipette tip to pick up the monoclonal bacteria, place them in 5ml of LB liquid medium containing antibiotics, and continue to culture for 10-12h;

[0074] 7. After extracting the recombinant plasmid from the bacterial solution with a plasmid extraction kit, digest it with restriction endonuclease EcoR I, and perform enzyme digestion identification by agarose electrophoresis;

[0075] 8. At the same time as step 7, part of the bacterial solution can be taken for bacterial solution PCR. The PCR product can be subjected to agarose gel electrophoresis to determine the band size and further identify whether the recombinant plasmid is correct.

[0076] 9. Perform bidirectional sequencing on the successfully identified bacterial solution. Once the sequence results are aligned correctly, it means that the recombinant plasmid has been successfully constructed and downstream experiments can be carried out.

[0077] like Figure 3 shown.

[0078] 2.2.2 Identification of homologous recombination plasmid by restriction enzyme digestion

[0079] After PCR, the product was subjected to agarose gel electrophoresis to check the band size. Figure 4 As shown, according to the EcoR I endonuclease results, combined with Figure 2 Plasmid map, three bands will appear in agarose gel electrophoresis: 7594bp, 5614bp, 466bp, and 1 in the figure matches the corresponding band, confirming that the recombinant plasmid is correct.

[0080] 2.2.3 Genotype identification of F0 generation mice

[0081] The injected fertilized eggs were transplanted into pseudo-pregnant female mice, and the mice born around 20 days later were F0 generation mice. Their genotypes were identified by PCR amplification and sequencing.

[0082] 2.2.3.1 Strategy for Genotyping F0 Generation Mice

[0083] like Figure 5 As shown, in Wild type (WT) mice, due to the absence of gene editing, the I / II primers can amplify a fragment of 8.3Kb, and the III / IV primers can amplify a fragment of 9.4Kb; in positive mice, due to the addition of the loxp system, the I / II primers can amplify a fragment of 5.4Kb, and the III / IV primers can amplify a fragment of 5.7Kb. The genotype of the F0 generation mice can be identified by the difference in the bands.

[0084] Homologous recombination positive mouse PCR identification scheme:

[0085] The 5' arm homologous recombination positive genome should amplify a 5.4kb fragment, and the negative genome should amplify a 8.3kb fragment; the 3' arm homologous recombination positive genome should amplify a 5.7kb fragment, and the negative genome should amplify a 9.4kb fragment.

[0086] 2.2.3.2 PCR identification results of homologous recombination positive F0 generation mice

[0087] The F0 mice with positive double-arm homologous recombination were No. 1, 9, and 14. The results of long-fragment PCR electrophoresis were as follows: Figure 6 As shown, in the 5' and 3' homology arms, the positive mice had obvious bands of 5.4 kb and 5.7 kb, respectively, while the WT mice had obvious bands of 8.3 kb and 9.4 kb.

[0088] 2.2.3.3 PCR identification method for F0 generation mice with positive 5' homology arm recombination

[0089] Primer information

[0090] Primer Sequence5'-->3' PrimerType I GGCATGGTAAAGGATTCACATCAAA Forward II TACACTCTTGATGCTTTGGGTTTTC Reverse

[0091] Reaction system:

[0092]

[0093]

[0094] KOD-Multi&Epi-(TOYOBO, Code No: KME-101) reaction conditions:

[0095] Step# Temperature(℃) Time Note 1 94 3min - 2 98 20min - 3 63 20min - 4 68 4min repeatsteps2-4for35cycles 5 68 5min - 6 12 - hold

[0096] 2.2.3.4 Primer information for PCR identification of F0 generation mice with positive 3' homology arm recombination

[0097] Primer Sequence5'-->3' PrimerType III TCCTGTGTTGACATAGTTCTTTGGA Forward IV TGTCATGTTTACCTCTCCAGACATT Reverse

[0098] Reaction system:

[0099]

[0100]

[0101] KOD-Multi&Epi-(TOYOBO, Code No: KME-101)

[0102] Reaction conditions:

[0103] Step# Temperature(℃) Time Note 1 94 3min - 2 98 20min - 3 63 20min - 4 68 4min repeatsteps2-4for35cycles 5 68 5min - 6 12 - hold

[0104] 2.2.4 Obtaining F1 generation mice and identifying their genotypes

[0105] Since the cleavage rate of the fertilized egg is very fast in the early stage, the F0 generation mice obtained are chimeras and may not have the ability to stably inherit. They need to be subcultured to obtain F1 generation mice with stable inheritance. F0 generation positive mice are mated with wild-type C57BL / 6J mice to obtain F1 generation mice, and their genotypes are identified by PCR method and sequencing.

[0106] 2.2.4.1 PCR Identification of 5' and 3' Homologous Arms of F1 Mice

[0107] The PCR identification strategy and method are the same as those in 2.3 F0 generation mouse identification. The electrophoresis results of PCR identification of 5' and 3' homology arms of F1 generation mice are as follows: Figure 7 As shown in A and 7B. The positive mice identified by PCR were: 1, 6, 8, 10, 11, 12, 13, 14, 15, 20, 22, and 23; all were confirmed to be positive by sequencing.

[0108] 2.2.4.2 PCR identification and sequencing results of F1 generation mice

[0109] The PCR identification products of F1 positive mice were sequenced, and a total of 4 sequencing reactions were performed. The corresponding regions of the sequencing reactions were as follows: Figure 8Among them, 2 sequencing reactions were performed for 5' homology arm identification and PCR product sequencing, which were marked as 1 and 2 respectively; 2 sequencing reactions were performed for 3' homology arm identification and PCR product sequencing, which were marked as 3 and 4 respectively.

[0110] 2.2.4.3 Number and basic information of F1 positive mice

[0111] The numbers and basic information of F1 positive mice are shown in the table below;

[0112] Basic information of F1 positive mice

[0113]

[0114] 3. 6030442E23Rik conditional knockout mice

[0115] 6030442E23Rik conditional knockout mice were hybridized with Tek-CreERT2 mice (CRISPR gene editing technology was used to insert Cre into the stop codon of the mouse Tek gene, which is a tool mouse for conditional knockout of endothelial cells. This strain of mice is currently available on the market) to obtain 6030442E23Rik- / -Tek-CreERT2 mice. Tamoxifen was then dissolved in corn oil to a final concentration of 20 mg / ml. Tamoxifen was then injected intraperitoneally 5 times, once every other day, at a dose of 120 mg / kg of mouse body weight. A mouse model with endothelial cell 6030442E23Rik specific knockout was obtained 7 days after the last injection.

[0116] The expression of 6030442E23Rik gene in mouse aorta (especially aortic endothelial cells) increases with age, and this gene may be used as a detection indicator of vascular aging in mice. The endothelial cell 6030442E23Rik specific knockout mouse model is an important mouse model for studying vascular endothelial aging.

[0117] Identification of a mouse model with endothelial cell-specific knockout of 6030442E23Rik:

[0118] 1. qPCR method: First, isolate mouse aortic endothelial cells. Thaw the matrix gel containing growth factors completely at 4°C overnight. Coat the pre-cooled 35mm culture dish with 1mL of matrix gel and place it in an incubator at 37°C for 20 minutes to solidify the matrix gel. Isolate the mouse thoracic aorta segment and inoculate it with the lumen side down on the ECM matrix gel supplemented with endothelial cell growth factor, 10% FBS and 1% penicillin / streptomycin. On the 4th day, the aortic segment was gently removed from the matrix gel without interrupting the growth of endothelial cells. After 3-4 days of proliferation, the mouse aortic endothelial cells were digested with trypsin and re-seeded on a 0.1% gelatin-coated cell culture plate. The mouse aortic endothelial cells were then extracted for RT-PCR to verify the expression of 6030442E23Rik.

[0119] 2. Fluorescence in situ hybridization (FISH) method: First, a 6030442E23Rik-specific probe was synthesized and constructed. Then, mouse aortic tissue was obtained and the expression of 6030442E23Rik in mouse aortic endothelial cells was identified through fixation, embedding, dewaxing, protease treatment, denaturation, fluorescence in situ hybridization, and fluorescence microscopy.

[0120] 4. Post-delivery work

[0121] 4.1 Mouse Validation

[0122] The numbering principle of mice is as follows Fig. 9 shown.

[0123] 4.2 Subsequent mouse breeding plan

[0124] Unless otherwise specified, all delivered flox mice were flox heterozygous mice (geneflox / +).

[0125] 4.2.1 Brief process and suggestions for subsequent experimental mouse breeding

[0126] 4.2.1.1 A brief procedure for subsequent experimental mouse breeding is as follows Fig.10 As shown:

[0127] (1) The obtained flox heterozygous mice (gene flox / + ) is divided into two parts:

[0128] Some of the flox mice were mated with Cre mice to obtain both flox-positive and Cre-positive mice (these mice are abbreviated as: gene flox / + :Cre+) and flox-positive and Cre-negative mice (gene flox / +); some flox mice were self-fertilized to obtain flox homozygous (the mice are abbreviated as: gene flox / flox ) and flox heterozygous mice (gene flox / + ).

[0129] (2) To obtain flox homozygous and Cre-positive mice, there are two breeding methods:

[0130] One method is to obtain flox and Cre double positive heterozygous mice (gene flox / + :Cre+) and flox heterozygous mice (gene flox / + ) mating, and finally obtained the experimental group mice with flox homozygosity and Cre positive (the mice are abbreviated as: gene flox / flox : Cre+, the proportion of offspring of this mouse is 1 / 8) and the control group of mice homozygous for flox and Cre negative (gene flox / flox , the proportion of offspring of this mouse is: 1 / 8);

[0131] Another method is to obtain flox and Cre double positive heterozygous mice (gene flox / + :Cre+) and flox homozygous mice (gene flox / flox ) mating, and finally obtained the experimental group mice with flox homozygous and Cre positive (gene flox / flox : Cre+, the proportion of offspring of this mouse is 1 / 4) and the control group of mice homozygous for flox and Cre negative (gene flox / flox , the proportion of offspring of this mouse is: 1 / 4).

[0132] Note: The above breeding scheme for experimental mice is only a reference scheme. During the mouse breeding process, the situation varies depending on the number of mice of various genotypes. Please make adjustments according to the actual situation.

[0133] 4.2.2 Subsequent mouse genotyping protocol

[0134] After the delivered flox mice are verified to be problem-free, the mouse genotype can be identified by short-fragment PCR during the subsequent mouse mating and breeding process. The primers and conditions required for mouse genotype identification in the subsequent mouse breeding steps are as follows. There are many options for mouse genotype identification. This report only gives one set of options. Customers can also design primers themselves according to the design principles we give. There are no special requirements for primer design software. The PrimerSelect program in the conventional DNASTAR software can meet the requirements (the relevant software can be downloaded through online search).

[0135] 4.2.2.1 Identification of flox mouse genotype (used to identify flox homozygous, heterozygous and wild type)

[0136] The principle of flox mouse genotype identification based on the Cas9 strategy is: after the loxp site is inserted, the wild type and mutant PCR identification are performed, and the different sizes of the PCR product fragments are used to distinguish different genotypes. This report only gives the primer position diagrams of two sets of schemes (P1, P2 primer pairs and P3, P4 primer pairs). The primer sequence information and specific PCR identification methods of one set of schemes are for reference; the primer sequence information and specific PCR identification methods of the other set of schemes are for your own design and verification. Users can perform identification according to the identification schemes and methods we provide, or they can design their own.

[0137] 4.2.2.2 Schematic diagram of PCR identification primer positions

[0138] like Fig.11 As shown, primers can be set for identification according to the positions of the 5' homology arm, the target gene region, and the 3' homology arm. Specifically, primers P1 and P2 can be designed to cover the flox sequence at the 5' end of the target gene, and primers P3 and P4 can also be designed to cover the flox sequence at the 3' end of the target gene.

[0139] 4.2.2.3 PCR identification

[0140]

[0141]

[0142] 4.2.3 DNA level Cre activity verification

[0143] Usually, a small piece of tissue expressing Cre is taken, genomic DNA is extracted, and the flox region is amplified by PCR. The presence or absence of the flox region is used to qualitatively determine whether Cre is working.

[0144] 4.2.3.1 Schematic diagram of PCR identification primer positions

[0145] like Fig.13 As shown, primers can be set for identification according to the positions of the 5' homology arm, the target gene region, and the 3' homology arm. Specifically, the P5 and P6 primers are designed to cover the target gene and its 5' and 3' end flox sequences; this sequence has different PCR products before and after Cre action.

[0146] 4.2.3.2 PCR identification conditions for whether Cre is effective

[0147]

[0148]

[0149] 4.3 Analysis of sequencing results

[0150] 4.3.1 Sequencing results of PCR identification products of F1 generation mice and comparison with target sequences

[0151] The sequencing comparison results take positive mouse No. 1 as an example.

[0152] 4.3.2 PCR identification and sequencing results of 5' homology arm of F1 mice

[0153] 1# Sequencing reaction comparison results are as follows Fig.15 As shown, Query is the target sequence (E23Rik recombinatedgenomic DNA sequence), Subject is the sequencing result, and the red underline is the 5arm homology arm sequence.

[0154] 2# Sequencing reaction comparison results are as follows Fig.16 As shown, Query is the target sequence (E23Rik recombinatedgenomic DNA sequence), Subject is the sequencing result, the red box base is the Loxp sequence, and the red underline is the 5arm homology arm sequence.

[0155] 4.3.3 PCR identification and sequencing results of 3' homology arm of F1 mice

[0156] 3# Sequencing reaction comparison results are as follows Fig.17 As shown, Query is the target sequence (E23Rik recombinatedgenomic DNA sequence), Subject is the sequencing result, the red box base is the Loxp sequence, and the red underline is the 3arm homology arm sequence.

[0157] 4# Sequencing reaction comparison results are as follows Fig.18 As shown, Query is the target sequence (E23Rik recombinatedgenomic DNA sequence), Subject is the sequencing result, and the red underline is the 3arm homology arm sequence.

[0158] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention, rather than to limit the protection scope of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents without departing from the essence and scope of the technical solution of the present invention.

Claims

1. A method for constructing a mouse model of endothelial cell 6030442E23Rik gene specific knockout, characterized in that: The construction method includes: 6030442E23Rik conditional knockout mice were hybridized with Tek-CreERT2 mice to obtain 6030442E23Rik - / - Tek-CreERT2 mice; Tamoxifen was dissolved in corn oil to a final concentration of 20 mg / ml, and injected intraperitoneally 5 times at a dose of 120 mg / kg mouse body weight, once every other day. A mouse model with endothelial cell 6030442E23Rik specific knockout was obtained 7 days after the last injection.

2. The method for constructing an endothelial cell 6030442E23Rik gene-specific knockout mouse model according to claim 2, characterized in that: The construction process of Tek-CreERT2 mice includes: CRISPR gene editing technology was used to insert Cre into the stop codon of the mouse Tek gene to obtain Tek-CreERT2 mice.

3. The method for constructing an endothelial cell 6030442E23Rik gene-specific knockout mouse model according to claim 2, characterized in that: The construction process of 6030442E23Rik conditional knockout mice includes: Cas9 mRNA and gRNA were obtained by in vitro transcription; homologous recombination vectors were constructed by In-Fusion cloning; Cas9 mRNA, gRNA and homologous recombination vectors were microinjected into fertilized eggs of C57BL / 6J mice to obtain F0 mice, and the F0 mice that were positive by PCR amplification and sequencing were mated with C57BL / 6J mice to obtain positive F1 mice.

4. The method for constructing an endothelial cell 6030442E23Rik gene-specific knockout mouse model according to claim 3, characterized in that: The primer sequences of gRNA include gRNA1 and gRNA2. The nucleotide sequences of gRNA1 and gRNA2 are as follows: gRNA1: 5'-GCCAATAAGGTTTTATCAGCTGG-3'; gRNA2: 5'-GCTGGAGACCTTATTCTATTGGG-3'.

5. The method for constructing an endothelial cell 6030442E23Rik gene-specific knockout mouse model according to claim 4, characterized in that: The homologous recombination vector contains a 2.9 kb 5' homology arm, a 2.2 kb flox region and a 2.6 kb 3' homology arm.

6. The method for constructing an endothelial cell 6030442E23Rik gene-specific knockout mouse model according to claim 5, characterized in that: The identification scheme of F0 generation mice is as follows: The 5' arm homologous recombination positive genome should amplify a 5.4kb fragment, and the negative genome should amplify a 8.3kb fragment; the 3' arm homologous recombination positive genome should amplify a 5.7kb fragment, and the negative genome should amplify a 9.4kb fragment.

7. The method for constructing an endothelial cell 6030442E23Rik gene-specific knockout mouse model according to claim 6, characterized in that: The PCR primer sequences for the 5' homology arms are as follows: Forward-GGCATGGTAAAGGATTCACATCAAA; Reverse-TACACTCTTGATGCTTGGGTTTTC.

8. The method for constructing an endothelial cell 6030442E23Rik gene-specific knockout mouse model according to claim 7, characterized in that: The PCR primer sequences for the 3' homology arms are as follows: Forward-TCCTGTGTTGACATAGTTCTTTGGA; Reverse-TGTCATGTTTACCTCTCCAGACATT.

9. Application of endothelial cell 6030442E23Rik gene specific knockout mouse model in the study of vascular endothelial aging.

Citation Information

Patent Citations

  • LINC00702 and application thereof to regulation of cardiovascular system

    CN107326072A

  • Method for constructing mouse model for conditional knockout of CCR5 gene of endothelial cell

    CN107858373A

  • Application of promoting expression of LncMAAT gene

    CN110169977A

  • Construction method of endothelial cell specific pfn1 gene knockout mouse model

    CN114150023A

  • Vascular endothelial cell PDHA1 gene specific knockout mouse construction experiment method

    CN114181955A

Cited By

  • Construction method and application of Cre tool mouse for specifically targeting corneal endothelial cells

    CN122382139A